{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:46:57Z","timestamp":1791935217825,"version":"4.3.4"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"DOI":"10.1007\/s11427-025-3541-0","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:23:55Z","timestamp":1791872635000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optimization of lipid nanoparticles reduces hepatic accumulation and enhances local delivery of mRNA"],"prefix":"10.1007","author":[{"given":"Yue","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoxian","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhi","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongchang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,10]]},"reference":[{"key":"3541_CR1","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","volume":"14","author":"A Akinc","year":"2019","unstructured":"Akinc, A., Maier, M.A., Manoharan, M., Fitzgerald, K., Jayaraman, M., Barros, S., Ansell, S., Du, X., Hope, M.J., Madden, T.D., et al. (2019). The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs. Nat Nanotechnol 14, 1084\u20131087.","journal-title":"Nat Nanotechnol"},{"key":"3541_CR2","doi-asserted-by":"publisher","first-page":"102037","DOI":"10.1016\/j.xcrm.2025.102037","volume":"6","author":"R Bai","year":"2025","unstructured":"Bai, R., Guo, W., Zhang, T., Ren, S., Liu, J., Xiao, P., Zhang, J., Sun, W., Yang, J., Ma, Y., et al. (2025). Single-cut gene therapy in a one-step generated rhesus monkey model of Duchenne muscular dystrophy. Cell Rep Med 6, 102037.","journal-title":"Cell Rep Med"},{"key":"3541_CR3","doi-asserted-by":"publisher","first-page":"5357","DOI":"10.1016\/j.cell.2024.07.023","volume":"187","author":"DW Brown","year":"2024","unstructured":"Brown, D.W., Wee, P., Bhandari, P., Bukhari, A., Grin, L., Vega, H., Hejazi, M., Sosnowski, D., Ablack, J., Clancy, E.K., et al. (2024). Safe and effective in vivo delivery of DNA and RNA using proteolipid vehicles. Cell 187, 5357\u20135375.e24.","journal-title":"Cell"},{"key":"3541_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.2217\/nnm-2020-0428","volume":"16","author":"D Chen","year":"2021","unstructured":"Chen, D., Ganesh, S., Wang, W., Lupieri, A., and Amiji, M. (2021). Role of vitronectin-rich protein corona on tumor-specific siRNA delivery and transfection with lipid nanoparticles. Nanomedicine 16, 535\u2013551.","journal-title":"Nanomedicine"},{"key":"3541_CR5","doi-asserted-by":"publisher","first-page":"18806","DOI":"10.1039\/C9NR05788A","volume":"11","author":"D Chen","year":"2019","unstructured":"Chen, D., Parayath, N., Ganesh, S., Wang, W., and Amiji, M. (2019). The role of apolipoprotein- and vitronectin-enriched protein corona on lipid nanoparticles for in vivo targeted delivery and transfection of oligonucleotides in murine tumor models. Nanoscale 11, 18806\u201318824.","journal-title":"Nanoscale"},{"key":"3541_CR6","doi-asserted-by":"publisher","first-page":"e2309472120","DOI":"10.1073\/pnas.2309472120","volume":"120","author":"J Chen","year":"2023","unstructured":"Chen, J., Xu, Y., Zhou, M., Xu, S., Varley, A.J., Golubovic, A., Lu, R.X.Z., Wang, K.C., Yeganeh, M., Vosoughi, D., et al. (2023). Combinatorial design of ionizable lipid nanoparticles for muscle-selective mRNA delivery with minimized off-target effects. Proc Natl Acad Sci USA 120, e2309472120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3541_CR7","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","volume":"15","author":"Q Cheng","year":"2020","unstructured":"Cheng, Q., Wei, T., Farbiak, L., Johnson, L.T., Dilliard, S.A., and Siegwart, D.J. (2020). Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing. Nat Nanotechnol 15, 313\u2013320.","journal-title":"Nat Nanotechnol"},{"key":"3541_CR8","doi-asserted-by":"publisher","first-page":"1805308","DOI":"10.1002\/adma.201805308","volume":"30","author":"Q Cheng","year":"2018","unstructured":"Cheng, Q., Wei, T., Jia, Y., Farbiak, L., Zhou, K., Zhang, S., Wei, Y., Zhu, H., and Siegwart, D.J. (2018). Dendrimer-based lipid nanoparticles deliver therapeutic FAH mRNA to normalize liver function and extend survival in a mouse model of hepatorenal tyrosinemia type I. Adv Mater 30, 1805308.","journal-title":"Adv Mater"},{"key":"3541_CR9","doi-asserted-by":"publisher","first-page":"e2109256118","DOI":"10.1073\/pnas.2109256118","volume":"118","author":"SA Dilliard","year":"2021","unstructured":"Dilliard, S.A., Cheng, Q., and Siegwart, D.J. (2021). On the mechanism of tissue-specific mRNA delivery by selective organ targeting nanoparticles. Proc Natl Acad Sci USA 118, e2109256118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3541_CR10","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1056\/NEJMoa2412309","volume":"391","author":"M Fontana","year":"2024","unstructured":"Fontana, M., Solomon, S.D., Kachadourian, J., Walsh, L., Rocha, R., Lebwohl, D., Smith, D., T\u00e4ubel, J., Gane, E.J., Pilebro, B., et al. (2024). CRISPR-Cas9 gene editing with nexiguran ziclumeran for ATTR cardiomyopathy. N Engl J Med 391, 2231\u20132241.","journal-title":"N Engl J Med"},{"key":"3541_CR11","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1021\/acs.bioconjchem.0c00366","volume":"31","author":"V Francia","year":"2020","unstructured":"Francia, V., Schiffelers, R.M., Cullis, P.R., and Witzigmann, D. (2020). The biomolecular corona of lipid nanoparticles for gene therapy. Bioconjug Chem 31, 2046\u20132059.","journal-title":"Bioconjug Chem"},{"key":"3541_CR12","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.3762\/bjnano.16.133","volume":"16","author":"P Gao","year":"2025","unstructured":"Gao, P. (2025). PEGylated lipids in lipid nanoparticle delivery dynamics and therapeutic innovation. Beilstein J Nanotechnol 16, 1914\u20131930.","journal-title":"Beilstein J Nanotechnol"},{"key":"3541_CR13","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/s41565-023-01404-4","volume":"18","author":"X Han","year":"2023","unstructured":"Han, X., Alameh, M.G., Butowska, K., Knox, J.J., Lundgreen, K., Ghattas, M., Gong, N., Xue, L., Xu, Y., Lavertu, M., et al. (2023). Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines. Nat Nanotechnol 18, 1105\u20131114.","journal-title":"Nat Nanotechnol"},{"key":"3541_CR14","doi-asserted-by":"publisher","first-page":"7233","DOI":"10.1038\/s41467-021-27493-0","volume":"12","author":"X Han","year":"2021","unstructured":"Han, X., Zhang, H., Butowska, K., Swingle, K.L., Alameh, M.G., Weissman, D., and Mitchell, M.J. (2021). An ionizable lipid toolbox for RNA delivery. Nat Commun 12, 7233.","journal-title":"Nat Commun"},{"key":"3541_CR15","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s13311-022-01197-9","volume":"19","author":"C Happi Mbakam","year":"2022","unstructured":"Happi Mbakam, C., Lamothe, G., Tremblay, G., and Tremblay, J.P. (2022). CRISPR-Cas9 gene therapy for Duchenne muscular dystrophy. Neurotherapeutics 19, 931\u2013941.","journal-title":"Neurotherapeutics"},{"key":"3541_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1208\/s12248-023-00833-2","volume":"25","author":"M Herrera-Barrera","year":"2023","unstructured":"Herrera-Barrera, M., Gautam, M., Lokras, A., Vlasova, K., Foged, C., and Sahay, G. (2023). Lipid nanoparticle-enabled intracellular delivery of prime editors. AAPS J 25, 65.","journal-title":"AAPS J"},{"key":"3541_CR17","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","volume":"383","author":"LA Jackson","year":"2020","unstructured":"Jackson, L.A., Anderson, E.J., Rouphael, N.G., Roberts, P.C., Makhene, M., Coler, R.N., McCullough, M.P., Chappell, J.D., Denison, M.R., Stevens, L.J., et al. (2020). An mRNA vaccine against SARS-CoV-2\u2014preliminary report. N Engl J Med 383, 1920\u20131931.","journal-title":"N Engl J Med"},{"key":"3541_CR18","doi-asserted-by":"publisher","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","volume":"15","author":"KJ Kauffman","year":"2015","unstructured":"Kauffman, K.J., Dorkin, J.R., Yang, J.H., Heartlein, M.W., DeRosa, F., Mir, F.F., Fenton, O.S., and Anderson, D.G. (2015). Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs. Nano Lett 15, 7300\u20137306.","journal-title":"Nano Lett"},{"key":"3541_CR19","doi-asserted-by":"publisher","first-page":"27977","DOI":"10.1021\/acsnano.5c10648","volume":"19","author":"Y Kawaguchi","year":"2025","unstructured":"Kawaguchi, Y., Kimura, M., Karaki, T., Tanaka, H., Ono, C., Ishida, T., Matsuura, Y., Hirai, T., Akita, H., Shimizu, T., et al. (2025). Modulating immunogenicity and reactogenicity in mRNA-lipid nanoparticle vaccines through lipid component optimization. ACS Nano 19, 27977\u201328001.","journal-title":"ACS Nano"},{"key":"3541_CR20","doi-asserted-by":"publisher","first-page":"7101","DOI":"10.1038\/s41467-021-26714-w","volume":"12","author":"E Kenjo","year":"2021","unstructured":"Kenjo, E., Hozumi, H., Makita, Y., Iwabuchi, K.A., Fujimoto, N., Matsumoto, S., Kimura, M., Amano, Y., Ifuku, M., Naoe, Y., et al. (2021). Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice. Nat Commun 12, 7101.","journal-title":"Nat Commun"},{"key":"3541_CR21","doi-asserted-by":"publisher","first-page":"0017","DOI":"10.34133\/bmr.0017","volume":"28","author":"Y Lee","year":"2024","unstructured":"Lee, Y., Jeong, M., Lee, G., Park, J., Jung, H., Im, S., and Lee, H. (2024). Development of lipid nanoparticle formulation for the repeated administration of mRNA therapeutics. Biomater Res 28, 0017.","journal-title":"Biomater Res"},{"key":"3541_CR22","doi-asserted-by":"publisher","first-page":"8099","DOI":"10.1021\/acs.nanolett.5b03528","volume":"15","author":"B Li","year":"2015","unstructured":"Li, B., Luo, X., Deng, B., Wang, J., McComb, D.W., Shi, Y., Gaensler, K.M.L., Tan, X., Dunn, A.L., Kerlin, B.A., et al. (2015). An orthogonal array optimization of lipid-like nanoparticles for mRNA delivery in vivo. Nano Lett 15, 8099\u20138107.","journal-title":"Nano Lett"},{"key":"3541_CR23","doi-asserted-by":"publisher","first-page":"43414","DOI":"10.1021\/acsami.3c07854","volume":"15","author":"G Liu","year":"2023","unstructured":"Liu, G., Sun, P., Yan, J., Shao, P., and Feng, S. (2023). Regulation of nanoliposome rigidity and bioavailability of oligomeric proanthocyanidin with phytosterols containing different C3 branches. ACS Appl Mater Interfaces 15, 43414\u201343430.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3541_CR24","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1073\/pnas.0910603106","volume":"107","author":"KT Love","year":"2010","unstructured":"Love, K.T., Mahon, K.P., Levins, C.G., Whitehead, K.A., Querbes, W., Dorkin, J.R., Qin, J., Cantley, W., Qin, L.L., Racie, T., et al. (2010). Lipid-like materials for low-dose, in vivo gene silencing. Proc Natl Acad Sci USA 107, 1864\u20131869.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3541_CR25","doi-asserted-by":"publisher","first-page":"100299","DOI":"10.1016\/j.mtadv.2022.100299","volume":"16","author":"I Menon","year":"2022","unstructured":"Menon, I., Zaroudi, M., Zhang, Y., Aisenbrey, E., and Hui, L. (2022). Fabrication of active targeting lipid nanoparticles: challenges and perspectives. Mater Today Adv 16, 100299.","journal-title":"Mater Today Adv"},{"key":"3541_CR26","doi-asserted-by":"publisher","first-page":"12349","DOI":"10.1073\/pnas.93.22.12349","volume":"93","author":"KA Mislick","year":"1996","unstructured":"Mislick, K.A., and Baldeschwieler, J.D. (1996). Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc Natl Acad Sci USA 93, 12349\u201312354.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3541_CR27","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41586-021-03534-y","volume":"593","author":"K Musunuru","year":"2021","unstructured":"Musunuru, K., Chadwick, A.C., Mizoguchi, T., Garcia, S.P., DeNizio, J.E., Reiss, C.W., Wang, K., Iyer, S., Dutta, C., Clendaniel, V., et al. (2021). In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates. Nature 593, 429\u2013434.","journal-title":"Nature"},{"key":"3541_CR28","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s41467-020-14527-2","volume":"11","author":"S Patel","year":"2020","unstructured":"Patel, S., Ashwanikumar, N., Robinson, E., Xia, Y., Mihai, C., Griffith III, J.P., Hou, S., Esposito, A.A., Ketova, T., Welsher, K., et al. (2020). Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA. Nat Commun 11, 983.","journal-title":"Nat Commun"},{"key":"3541_CR29","doi-asserted-by":"publisher","first-page":"e05404","DOI":"10.1002\/smll.202505404","volume":"21","author":"S Porte","year":"2025","unstructured":"Porte, S., Vadhana, V., and Sengupta, D. (2025). A molecular view of lipid nanoparticles: insights into their morphology and structural plasticity. Small 21, e05404.","journal-title":"Small"},{"key":"3541_CR30","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1146\/annurev.cb.07.110191.001423","volume":"7","author":"KT Preissner","year":"1991","unstructured":"Preissner, K.T. (1991). Structure and biological role of vitronectin. Annu Rev Cell Biol 7, 275\u2013310.","journal-title":"Annu Rev Cell Biol"},{"key":"3541_CR31","doi-asserted-by":"publisher","first-page":"0045","DOI":"10.34133\/research.0045","volume":"6","author":"S Ren","year":"2023","unstructured":"Ren, S., Huang, M., Bai, R., Chen, L., Yang, J., Zhang, J., Guo, W., Ji, W., and Chen, Y. (2023). Efficient modulation of exon skipping via antisense circular RNAs. Research 6, 0045.","journal-title":"Research"},{"key":"3541_CR32","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s41587-021-00933-4","volume":"39","author":"T Rothgangl","year":"2021","unstructured":"Rothgangl, T., Dennis, M.K., Lin, P.J.C., Oka, R., Witzigmann, D., Villiger, L., Qi, W., Hruzova, M., Kissling, L., Lenggenhager, D., et al. (2021). In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels. Nat Biotechnol 39, 949\u2013957.","journal-title":"Nat Biotechnol"},{"key":"3541_CR33","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.jconrel.2024.04.022","volume":"370","author":"JB Simonsen","year":"2024","unstructured":"Simonsen, J.B. (2024). Lipid nanoparticle-based strategies for extrahepatic delivery of nucleic acid therapies\u2014challenges and opportunities. J Control Release 370, 763\u2013772.","journal-title":"J Control Release"},{"key":"3541_CR34","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41596-022-00755-x","volume":"18","author":"X Wang","year":"2023","unstructured":"Wang, X., Liu, S., Sun, Y., Yu, X., Lee, S.M., Cheng, Q., Wei, T., Gong, J., Robinson, J., Zhang, D., et al. (2023). Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery. Nat Protoc 18, 265\u2013291.","journal-title":"Nat Protoc"},{"key":"3541_CR35","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1038\/s41467-025-57831-5","volume":"16","author":"R Wu","year":"2025","unstructured":"Wu, R., Li, P., Xiao, P., Zhang, S., Wang, X., Liu, J., Sun, W., Chang, Y., Ai, X., Chen, L., et al. (2025). Activation of endogenous full-length utrophin by MyoAAV-UA as a therapeutic approach for Duchenne muscular dystrophy. Nat Commun 16, 2398.","journal-title":"Nat Commun"},{"key":"3541_CR36","doi-asserted-by":"publisher","first-page":"101463","DOI":"10.1016\/j.omtm.2025.101463","volume":"33","author":"S Xu","year":"2025","unstructured":"Xu, S., Hu, Z., Song, F., Xu, Y., and Han, X. (2025). Lipid nanoparticles: composition, formulation, and application. Mol Ther Meth Clin Dev 33, 101463.","journal-title":"Mol Ther Meth Clin Dev"},{"key":"3541_CR37","doi-asserted-by":"publisher","first-page":"123047","DOI":"10.1016\/j.biomaterials.2024.123047","volume":"317","author":"J Yu","year":"2025","unstructured":"Yu, J., Li, Q., Zhang, C., Wang, Q., Luo, S., Wang, X., Hu, R., and Cheng, Q. (2025). Targeted LNPs deliver IL-15 superagonists mRNA for precision cancer therapy. Biomaterials 317, 123047.","journal-title":"Biomaterials"},{"key":"3541_CR38","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1007\/s11427-024-2697-3","volume":"67","author":"D Zhang","year":"2024","unstructured":"Zhang, D., Zheng, R., Chen, Z., Wang, L., Chen, X., Yang, L., Huo, Y., Yin, S., Zhang, D., Huang, J., et al. (2024). Lipid nanoparticle-mediated base-editing of the Hao1 gene achieves sustainable primary hyperoxaluria type 1 therapy in rats. Sci China Life Sci 67, 2575\u20132586.","journal-title":"Sci China Life Sci"},{"key":"3541_CR39","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1208\/s12248-021-00608-7","volume":"23","author":"H Zu","year":"2021","unstructured":"Zu, H., and Gao, D. (2021). Non-viral vectors in gene therapy: recent development, challenges, and prospects. AAPS J 23, 78.","journal-title":"AAPS J"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-025-3541-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11427-025-3541-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-025-3541-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:17:30Z","timestamp":1791933450000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11427-025-3541-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,10]]},"references-count":39,"alternative-id":["3541"],"URL":"https:\/\/doi.org\/10.1007\/s11427-025-3541-0","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,10]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest. All animal care and experimental procedures were approved by the Experimental Animal Centre of Kunming University of Science and Technology (permit No. PZWH (Yunnan) K2023-0029 and AP-KUST-202510020095) and followed the National Institutes of Health care guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance and ethics"}}]}}